IRCT20170612034484N1

Compare the effect of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics

Comparison of Capsule extract of walnut leaves and metformin on blood sugar, cholesterol and liver enzyme type II diabetics
Investigator·Phase 1·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Investigator
Location
Iran
Timeline & enrollment
Phase
Phase 1
Start date
Apr 30, 2017
End date
N/A
ICD-10 classifications
Other specified diabetes mellitus without complicationsUnspecified diabetes mellitus without complicationsOther specified diabetes mellitusOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
Iranian Registry Of Clinical Trial
Trial ID
IRCT20170612034484N1
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for IRCT20170612034484N1 through Pure Global AI's free database. This Phase 1 trial is sponsored by Investigator and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.